Genetic variation in HBV infection: genotypes and mutants

Journal of Clinical Virology

Volumn 36, Issue SUPPL. 1, 2006, Pages

  Günther, Stephan ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Genotypes; Hepatitis B virus; Mutants; Occult hepatitis B

Indexed keywords

ARTICLE; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; MUTANT; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN;

GENOTYPE; HEPATITIS B, CHRONIC; MUTATION; VARIATION (GENETICS);

EID: 33745829443     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(06)80002-8     Document Type: Article

References (126)

1. Abe K., Kiuchi T., Aiba N., Tran H., Ding X., Yamaguchi M., et al. Complete nucleotide sequence of hepatitis B virus isolated from two infants with fulminant hepatitis. Jpn J Infect Dis 56 (2003) 38-39
2. Arauz-Ruiz P., Norder H., Robertson B., and Magnius L. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83 (2002) 2059-2073
3. Aritomi T., Yatsuhashi H., Fujino T.a.^K., Inoue O., Koga M., et al. Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan. J Gastroenterol Hepatol 13 (1998) 1125-1132
4. Bahn A., Gerner P., Martine U., Bortolotti F., and Wirth S. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. J Hepatol 27 (1997) 973-978
5. Bancroft W., Mundon F., and Russell P. Detection of additional antigenic determinants of hepatitis B antigen. J Immunol 109 (1972) 842-848
6. Bauer T., Weinberger K., and Jilg W. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 35 (2002) 455-465
7. Beasley R., Hwang L., Lin C., and Chien C. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 (1981) 1129-1133
8. Bertoletti A., Costanzo A., Chisari F., Levreto M., Artini M., Sette A., et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180 (1994) 933-943
9. Bhat R., Ulrich P., and Vyas G. Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology 11 (1990) 271-276
10. Blackberg J., and Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 33 (2000) 992-997
11. Blitz L., Pujol F., Swenson P., Porto L., Atencio R., Araujo M., et al. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol 36 (1998) 648-651
12. Blum H., Galun E., Liang T., von Weizsäker F., and Wands J. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 65 (1991) 1836-1842
13. Blum H., Liang T., Galun E., and Wands J. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 14 (1991) 56-63
14. Bock C., Buerke B., Tillmann H., Tacke F., Kliem V., Manns M., et al. Relevance of hepatitis B core gene deletions in patients after kidney transplantation. Gastroenterology 124 (2003) 1809-1820
15. Bollyky P., and Holmes E. Reconstructing the complex evolutionary history of hepatitis B virus. J Mol Evol 49 (1999) 130-141
16. Bowyer S., and Sim J. Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J Gen Virol 81 (2000) 379-392
17. Bozkaya H., Akarca U., Ayola B., and Lok A. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 26 (1997) 508-516
18. Buckwold V., Xu Z., Yen T., and Ou J. Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 78 (1997) 2055-2065
19. Cabrerizo M., Bartolomé J., Caramelo C., Barril G., and Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 32 (2000) 116-123
20. Ceres P., Stray S., and Zlotnick A. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L. J Virol 78 (2004) 9538-9543
21. Chaudhuri V., Tayal R., Nayak B., Acharya S., and Panda S. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127 (2004) 1356-1371
22. Chu C., Hussain M., and Lok A. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122 (2002) 1756-1762
23. Chu C., Keeffe E., Han S., Perrillo R., Min A., Soldevila-Pico C., et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125 (2003) 444-451
24. Chu C., Keeffe E., Han S., Perrillo R., Min A., Soldevila-Pico C., et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 38 (2003) 619-628
25. Dickson R., Everhart J., Lake J., Wei Y., Seaberg E., Wiesner R., et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 113 (1997) 1668-1674
26. Fares M., and Holmes E. A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54 (2002) 807-814
27. Fattovich G., Brollo L., Alberti A., Pontisso P., Giustina G., and Realdi G. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 8 (1988) 1651-1654
28. Fong T., Di Bisceglie A., Gerber M., Waggoner J., and Hoofnagle J. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18 (1993) 1313-1318
29. Friedt M., Gerner P., Lausch E., Trubel H., Zabel B., and Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29 (1999) 1252-1258
30. Friedt M., Gerner P., Wintermeyer P., and Wirth S. Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B. BMC Gastroenterol 4 (2004) 11
31. Fukuda R., Ishimura N., Kushiyama Y., Moriyama N., Ishihara S., Chowdhury A., et al. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-B, non-C chronic hepatitis. Microbiol Immunol 40 (1996) 481-488
32. Garfein R., Bower W., Loney C., Hutin Y., Xia G., Jawanda J., et al. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 40 (2004) 865-873
33. Gerner P., Friedt M., Oettinger R., Lausch E., and Wirth S. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children. Virology 245 (1998) 163-172
34. Grethe S., Monazahian M., Bohme I., and Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 72 (1998) 7692-7696
35. Günther S., Meisel H., Reip A., Miska S., Krüger D., and Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 187 (1992) 271-279
36. Günther S., Baginski S., Kissel H., Reinke P., Krüger D., Will H., et al. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology 24 (1996) 751-758
37. Günther S., Piwon N., Iwanska A., Schilling R., Meisel H., and Will H. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 70 (1996) 8318-8331
38. Günther S., Sommer G., and Iwanska A. Heterogencity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 238 (1997) 363-371
39. Günther S., Sommer G., Plikat U., Iwanska A., Wain-Hobson S., Will H., et al. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G→A hypermutation. Virology 235 (1997) 104-108
40. Günther S., Paulij W., Meisel H., and Will H. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology 244 (1998) 146-160
41. Günther S., Fischer L., Pult J., Sterneck M., and Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 52 (1999) 25-137
42. Günther S., Piwon N., Jung A., Iwanska A., Schmitz H., and Will H. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 273 (2000) 286-299
43. Hallett R., Ngui S., Meigh R., Mutton K., Boxall E., and Teo C. Widespread dissemination in England of a stable and persistent hepatitis B virus variant. Clin Infect Dis 39 (2004) 945-952
44. Hannoun C., Hotal P., and Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81 (2000) 75-83
45. Hannoun C., Norder H., and Lindh M. An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol 81 (2000) 2267-2272
46. Hass M., Hannoun C., Kalinina T., Sommer G., Manegold C., and Günther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 42 (2005) 93-103
47. Hoofnagle J., Dusheiko G., Seeff L., Jones E., Waggoner J., and Bales Z. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 94 (1981) 744-748
48. Hou J., Wang Z., Cheng J., Lin Y., Lau G., Sun J., et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34 (2001) 1027-1034
49. Huo T., Wu J., Lee P., Chau G., Lui W., Tsay S., et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28 (1998) 231-236
50. Imamura T., Yokosuka O., Kurihara T., Kanda T., Fukai K., Imazeki F., et al. Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut 52 (2003) 1630-1637
51. Jeantet D., Chemin I., Mandrand B., Zoulim F., Trepo C., and Kay A. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35 (2002) 1215-1224
52. Kalinina T., Riu A., Fischer L., Will H., and Sterneck M. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 34 (2001) 385-394
53. Kao J., Chen P., Lai M., and Chen D. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118 (2000) 554-559
54. Kao J., Chen P., Lai M., and Chen D. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003) 327-334
55. Kato H., Orito E., Gish R., Bzowej N., Newsom M., Sugauchi F., et al. Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology 35 (2002) 922-929
56. Kato H., Orito E., Gish R., Sugauchi F., Suzuki S., Ueda R., et al. Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). J Virol 76 (2002) 6131-6137
57. Kato J., Hasegawa K., Torii N., Yamauchi K., and Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 23 (1996) 389-395
58. Khan N., Guarnieri M., Ahn S., Li J., Zhou Y., Bang G., et al. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 78 (2004) 3262-3270
59. Kidd-Ljunggren K., Miyakawa Y., and Kidd A. Genetic variability in hepatitis B virus. J Gen Virol 83 (2002) 1267-1280
60. Komori M., Yuki N., Nagaoka T., Yamashiro M., Mochizuki K., Kaneko A., et al. Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients. J Hepatol 35 (2001) 798-804
61. Kremsdorf D., Garreau F., Capel F., Petit M., and Brechot C. In vivo selection of a hepatitis B virus mutant with abnormal viral protein expression. J Gen Virol 77 (1996) 929-939
62. Kuhns M., McNamara A., Mason A., Campbell C., and Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 103 (1992) 1649-1656
63. Kurbanov F., Tanaka Y., Fujiwara K., Sugauchi F., Mbanya D., Zekeng L., et al. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 86 (2005) 2047-2056
64. Le Bouvier G. The heterogeneity of Australia antigen. J Infect Dis 123 (1971) 671-675
65. Lee P., Chang M., Lee C., Hsu H., Chen J., Chen P., et al. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology 12 (1990) 657-660
66. Li J., Tong S., Wen Y., Vitvitski L., Zhang Q., and Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 67 (1993) 5402-5410
67. Lindh M., Andersson A., and Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175 (1997) 1494-1497
68. Lindh M., Hannoun C., Dhillon A., Norkrans G., and Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179 (1999) 775-782
69. Liu C., Chen P., Lai M., Kao J., Chang C., Wu H., et al. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 124 (2003) 80-90
70. Lok A., and Lai C. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 8 (1988) 1130-1133
71. Lok A., Akarca U., and Greene S. Predictive value of precote hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance. Hepatology 21 (1995) 19-24
72. Mangia A., Chung Y., Hoofnagle J., Birkenmeyer L., Mushahwar I., and Di Bisceglie A. Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 41 (1996) 2447-2452
73. Marinos G., Torre F., Günther S., Thomas M., Will H., Williams R., et al. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 111 (1996) 183-192
74. Marusawa H., Uemoto S., Hijikata M., Ueda Y., Tanaka K., Shimotohno K., et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31 (2000) 488-495
75. Maruyama T., McLachlan A., Iino S., Koike K., Kurokawa K., and Milich D. The serology of chronic hepatitis B infection revisited. J Clin Invest 91 (1993) 2586-2595
76. Michalak T., Pasquinelli C., Guilhot S., and Chisari F. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 93 (1994) 230-239
77. Michalak T., Pardoe I., Coffin C., Churchill N., Freake D., Smith P., et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 29 (1999) 928-938
78. Michalak T., Mulrooney P., and Coffin C. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 78 (2004) 1730-1738
79. Minuk G., Sun D., Greenberg R., Zhang M., Hawkins K., Uhanova J., et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40 (2004) 1072-1077
80. Nakano T., Lu L., Hu X., Mizokami M., Orito E., Shapiro C., et al. Characterization of hepatitis B virus genotypes among Yucpa Indians in Venezuela. J Gen Virol 82 (2001) 359-365
81. Ni Y., Chang M., Hsu H., and Chen H. Long-term follow-up study of core gene deletion mutants in children with chronic hepatitis B virus infection. Hepatology 32 (2000) 124-128
82. Noguchi C., Ishine H., Tsuge M., Fujimoto Y., Imamura M., Takahashi S., et al. G to A hypermutation of hepatitis B virus. Hepatology 41 (2005) 626-633
83. Norder H., Couronce A., and Magnius L. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73 (1992) 3141-3145
84. Norder H., Hammas B., Lee S., Bile K., Courouce A., Mushahwar I., et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 74 (1993) 1341-1348
85. Norder H., Courouce A., and Magnius L. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198 (1994) 489-503
86. Norder H., Courouce A., Coursaget P., Echevarria J., Lee S., Mushahwar I., et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47 (2004) 289-309
87. Okamoto H., Imai M., Kametani M., Nakamura T., and Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 57 (1987) 231-236
88. Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R., Imai M., Miyakawa Y., et al. Typing hepatitis B virus by homology in nucleotide sequence comparison of surface antigen subtypes. J Gen Virol 69 (1988) 2575-2583
89. Orito E., Mizokami M., Ina Y., Moriyama E., Kameshima N., Yamamoto M., et al. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 86 (1989) 7059-7062
90. Orito E., Mizokami M., Sakugawa H., Michitaka K., Ishikawa K., Ichida T., et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 33 (2001) 218-223
91. Parekh S., Zoulim F., Ahn S., Tsai A., Li J., Kawai S., et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77 (2003) 6601-6612
92. Petrosillo N., Ippolito G., Solforosi L., Varaldo P., Clementi M., and Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol 38 (2000) 2975-2981
93. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Crax A., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102-110
94. Prince A., Lee D., and Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 41 (2001) 329-332
95. Pult I., Chouard T., Wieland S., Klemenz R., Yaniv M., and Blum H. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology 25 (1997) 1507-1515
96. Rodriguez-Frias F., Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R., et al. Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations. Hepatology 22 (1995) 1641-1647
97. Rokuhara A., Tanaka E., Yagi S., Mizokami M., Hashikura Y., Kawasaki S., et al. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome. J Med Virol 62 (2000) 471-478
98. Schories M., Peters T., and Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 33 (2000) 799-811
99. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol 82 (2001) 693-712
100. Sommer G., van Bommel F., and Will H. Genotype-specific synthesis and secretion of spliced hepatitis B virus genomes in hepatoma cells. Virology 271 (2000) 371-381
101. Stuyver L., De Gendt S., Van Geyt C., Zoulim F., Fried M., Schinazi R., et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81 (2000) 67-74
102. Su T., Lai C., Huang J., Lin L., Yauk Y., Chang C., et al. Hepatitis B virus transcript produced by RNA splicing. J Virol 63 (1989) 4011-4018
103. Suk F., Lin M., Newman M., Pan S., Chen S., Liu J., et al. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (197L) in human hepatitis B virus. J Virol 76 (2002) 12069-12077
104. Sumi H., Yokosuka O., Seki N., Arai M., Imazeki F., Kurihara T., et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37 (2003) 19-26
105. Sundkvist T., Hamilton G., Rimmer D., Evans B., and Teo C. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1 (1998) 48-50
106. Suspene R., Guetard D., Henry M., Sommer P., Wain-Hobson S., and Vartanian J. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 102 (2005) 8321-8326
107. Suzuki T., Masui N., Kajino K., Saito I., and Miyamura T. Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome. Proc Natl Acad Sci USA 86 (1989) 8422-8426
108. Takahashi K., Akahane Y., Hino K., Ohta Y., and Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 143 (1988) 2313-2326
109. Tang H., Raney A., and McLachlan A. Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. J Virol 75 (2001) 8937-8948
110. Tran A., Kremsdorf D., Capel F., Housset C., Dauguet C., Petit M., et al. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol 65 (1991) 3566-3574
111. Tsubota A., Kumada H., Takaki K., Chayama K., Kobayashi M., Suzuki Y., et al. Deletions in the hepatitis B virus core gene may influence the clinical cutcome in hepatitis B e antigen-posirive asymptomatic healthy carriers. J Med Virol 56 (1998) 287-293
112. Uchida T., Shimojima M., Gotoh K., Shikata T., Tanaka E., and Kiyosawa K. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 38 (1994) 281-285
113. Vieth S., Manegold C., Drosten C., Nippraschk T., and Gunther S. Sequence and phylogenetic analysis of hepatitis B virus gene type G isolated in Germany. Virus Gener 24 (2002) 153-156
114. Wai C., Fontana R., Polson J., Hussain M., Shakil A., Han S., et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United State. J Viral Hepat 12 (2005) 192-198
115. Wakita T., Kakumm S., Shibata M., Yoshioka K., Ito Y., Slanagawa T., et al. Detection of pre-C and core region muants of hepatitis B virus in chronic hepatitis B virus earriers. J Clin Invest 88 (1991) 1793-1801
116. Wang H., and Rogler C. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J Virol 65 (1991) 2381-2392
117. Waters J., Kennedy M., Voet P., Hanset P., Petre J., Carman W., et al. Loss of the common "A" determinat of hepatitis B surface antigen by a vaccine-inhiced escape inutant. J Clin Invest 90 (1992) 2543-2547
118. Whalley S., Brown D., Webster G., Jacobs R., Reignat S., Bertoletti A., et al. Evolution of hepatitis B virus during primary infection in humans: transient generation of cyfotoxic T-cell mutsnts. Gastroenterology 127 (2004) 1131-1138
119. Yang W., and Summers J. Illegitimate replication of linear hepadavirus DNA through nonhomologous recombination. J Virol 68 (1995) 4029-4036
120. Yang W., Mason W., and Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virustifected liver. J Virol 70 (1996) 4567-4575
121. Yotsuyanagi H., Yasuda K., Moriya K., Shintani Y., Fijie H., Tsutsumi T., et al. Frequent presence of HBV in the sera of HBsAg-negative anti-HBc-positive blood donors. Transfusion 41 (2000) 1093-1099
122. Yuan T., Lin M., Chen D., and Shih C. A defective inteference-like phenomenon of human hepatitis B virus in chronic carriers. J Virol 72 (1998) 578-584
123. Yuasa R., Takahashi K., Dien B., Binh N., Morishita T., Sato K., et al. Properties of hepatitis B virus genome recovered from Vietmanese patients with fulminant hepatitis in comparison with those of acute hepatitis. J Med Virol 61 (2000) 23-28
124. Yuki N., Nagaoka T.a.^M.a.^K., Kaneko A., Yamamoto K., et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 37 (2003) 1172-1179
125. Zhang Y., Nordenfelt E., and Hansson B. Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand J Infect Dis 28 (1996) 9-15
126. Zheng Y., Li J., and Ou J. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 78 (2004) 6908-6914